Rodgers 2021 Elife
Jump to navigation Jump to search
|Rodgers P, Collings A (2021) What have we learned? Elife 10:e75830. doi: 10.7554/eLife.75830|
Abstract: As the final outputs of the Reproducibility Project: Cancer Biology are published, it is clear that preclinical research in cancer biology is not as reproducible as it should be.
• Bioblast editor: Gnaiger E
- Journals have encouraged more complete reporting of methods and results in recent years, but there is still scope for improvement, especially when it comes to making data and code openly available. Many studies would benefit from greater input from experts in statistics, ideally before data are collected, and preregistration should help to reduce bias and increase rigor in certain types of studies. Increased preprinting will also help for most papers by increasing both readership and scrutiny, and by making new results available sooner. Lastly, a greater emphasis on science that is rigorous, as opposed to eye-catching, from researchers, institutions, funders and journals would benefit everyone.